Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system

Pain

Volumn 153, Issue 11, 2012, Pages 2226-2232

  Hoffmann, Jan ^a   Supronsinchai, Weera ^a   Andreou, Anna P ^a   Summ, Oliver ^a   Akerman, Simon ^a   Goadsby, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Headache; Migraine; TRPV1

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; A 993610; CANNABINOID 1 RECEPTOR; CAPSAICIN; OLVANIL; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG MECHANISM; EVOKED RESPONSE; MALE; NEUROTRANSMISSION; NONHUMAN; PRIMARY HEADACHE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SPREADING CORTICAL DEPRESSION; SYNAPTIC TRANSMISSION; TRIGEMINAL NERVE; TRIGEMINOVASCULAR SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAPSAICIN; MALE; MENINGEAL ARTERIES; MIGRAINE DISORDERS; NOCICEPTORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION; TRIGEMINAL NERVE; TRPV CATION CHANNELS;

EID: 84867572053     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2012.07.006     Document Type: Article

References (50)

1. G. Acs, M. Palkovits, and P.M. Blumberg Specific binding of [3H]resiniferatoxin by human and rat preoptic area, locus ceruleus, medial hypothalamus, reticular formation and ventral thalamus membrane preparations Life Sci 59 1996 1899 1908
2. S. Akerman, P.R. Holland, and P.J. Goadsby Diencephalic and brainstem mechanisms in migraine Nat Rev Neurosci 12 2011 570 584
3. S. Akerman, H. Kaube, and P.J. Goadsby Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception J Pharmacol Exp Ther 309 2004 56 63
4. A.I. Basbaum, D.M. Bautista, G. Scherrer, and D. Julius Cellular and molecular mechanisms of pain Cell 139 2009 267 284
5. H. Bolay, U. Reuter, A.K. Dunn, Z. Huang, D.A. Boas, and M.A. Moskowitz Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model Nat Med 8 2002 136 142
6. L. Brand, E. Berman, R. Schwen, M. Loomans, J. Janusz, R. Bohne, C. Maddin, J. Gardner, T. Lahann, R. Farmer, L. Jones, C. Chiabrando, and R. Fanelli NE-19550: a novel, orally active anti-inflammatory analgesic Drugs Exp Clin Res 13 1987 259 265
7. E.A. Campbell, A. Dray, and M.N. Perkins Comparison of capsaicin and olvanil as antinociceptive agents in vivo and in vitro Br J Pharmacol 98 1989 907P
8. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
9. K.M. Chu, M.P. Ngan, M.K. Wai, C.K. Yeung, P.L. Andrews, N. Percie du Sert, and J.A. Rudd Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret Neuropharmacology 58 2010 383 391
10. A.J. Davies, and R.A. North Electrophysiological and morphological properties of neurons in the substantia gelatinosa of the mouse trigeminal subnucleus caudalis PAIN® 146 2009 214 221
11. L. De Petrocellis, T. Bisogno, M. Maccarrone, J.B. Davis, A. Finazzi-Agro, and V. Di Marzo The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism J Biol Chem 276 2001 12856 12863
12. V. Di Marzo, P.M. Blumberg, and A. Szallasi Endovanilloid signaling in pain Curr Opin Neurobiol 12 2002 372 379
13. V. Di Marzo, and L. De Petrocellis Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs Curr Med Chem 17 2010 1430 1449
14. V. Di Marzo, I. Lastres-Becker, T. Bisogno, L. De Petrocellis, A. Milone, J.B. Davis, and J.J. Fernandez-Ruiz Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues Eur J Pharmacol 420 2001 123 131
15. S. Diamond, F. Freitag, S.B. Phillips, J.E. Bernstein, and J.R. Saper Intranasal civamide for the acute treatment of migraine headache Cephalalgia 20 2000 597 602
16. A. Dickenson, C. Hughes, A. Rueff, and A. Dray A spinal mechanism of action is involved in the antinociception produced by the capsaicin analogue NE 19550 (olvanil) PAIN® 43 1990 353 362
17. J. Donnerer, and F. Lembeck Analysis of the effects of intravenously injected capsaicin in the rat Naunyn Schmiedebergs Arch Pharmacol 320 1982 54 57
18. M. Dux, P. Santha, and G. Jancso Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat J Physiol 552 2003 859 867
19. B.M. Fusco, S. Marabini, C.A. Maggi, G. Fiore, and P. Geppetti Preventative effect of repeated nasal applications of capsaicin in cluster headache PAIN® 59 1994 321 325
20. N.R. Gavva, J.J.S. Treanor, A. Garami, L. Fang, S. Surapaneni, A. Akrami, F. Alvarez, A. Bak, M. Darling, A. Gore, G.R. Jang, J.P. Kesslak, L. Ni, M.H. Norman, G. Palluconi, M.J. Rose, M. Salfi, E. Tan, A.A. Romanovsky, C. Banfield, and G. Davar Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans PAIN® 136 2008 202 210
21. M. Hajós, K. Svensson, H. Nissbrandt, F. Obál, and A. Carlsson Effects of capsaicin on central monoaminergic mechanisms in the rat J Neur Transm 66 1986 221 242
22. T.W. Ho, L. Edvinsson, and P.J. Goadsby CGRP and its receptors provide new insights into migraine pathophysiology Nat Rev Neurol 6 2010 573 582
23. M. Hou, R. Uddman, J. Tajti, M. Kanje, and L. Edvinsson Capsaicin receptor immunoreactivity in the human trigeminal ganglion Neurosci Lett 330 2002 223 226
24. D.E. Hu, A.S. Easton, and P.A. Fraser TRPV1 activation results in disruption of the blood-brain barrier in the rat Br J Pharmacol 146 2005 576 584
25. D. Julius, and A.I. Basbaum Molecular mechanisms of nociception Nature 413 2001 203 210
26. H. Knotkova, M. Pappagallo, and A. Szallasi Capsaicin (TRPV1 agonist) therapy for pain relief: farewell or revival? Clin J Pain 24 2008 142 154
27. G. Lambert, J. Davis, J. Appleby, B. Chizh, K. Hoskin, and A. Zagami The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission Naunyn Schmiedebergs Arch Pharmacol 380 2009 311 325
28. A.A.P. Leão, and R.S. Morison Propagation of spreading cortical depression J Neurophysiol 8 1945 33 45
29. D.R. Marks, A. Rapoport, D. Padla, R. Weeks, R. Rosum, F. Sheftell, and F. Arrowsmith A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache Cephalalgia 13 1993 114 116
30. D. Melck, T. Bisogno, L. De Petrocellis, H. Chuang, D. Julius, M. Bifulco, and V. Di Marzo Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors Biochem Biophys Res Commun 262 1999 275 284
31. E. Mezey, Z.E. Toth, D.N. Cortright, M.K. Arzubi, J.E. Krause, R. Elde, A. Guo, P.M. Blumberg, and A. Szallasi Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human Proc Natl Acad Sci USA 97 2000 3655 3660
32. N. Offenhauser, T. Zinck, J. Hoffmann, K. Schiemann, S. Schuh-Hofer, W. Rohde, G. Arnold, U. Dirnagl, I. Jansen-Olesen, and U. Reuter CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion Cephalalgia 25 2005 225 236
33. E. Palazzo, V. de Novellis, I. Marabese, D. Cuomo, F. Rossi, L. Berrino, and S. Maione Interaction between vanilloid and glutamate receptors in the central modulation of nociception Eur J Pharmacol 439 2002 69 75
34. A. Patapoutian, S. Tate, and C.J. Woolf Transient receptor potential channels: targeting pain at the source Nat Rev Drug Discov 8 2009 55 68
35. A.M. Patwardhan, N.A. Jeske, T.J. Price, N. Gamper, A.N. Akopian, and K.M. Hargreaves The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin Proc Natl Acad Sci USA 103 2006 11393 11398
36. S.C. Pingle, J.A. Matta, and G.P. Ahern Capsaicin receptor: TRPV1 a promiscuous TRP channel Handb Exp Pharmacol 179 2007 155 171
37. L.S. Premkumar, and G.P. Ahern Induction of vanilloid receptor channel activity by protein kinase C Nature 408 2000 985 990
38. J.C. Roberts, J.B. Davis, and C.D. Benham [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution Brain Res 995 2004 176 183
39. J.R. Saper, J. Klapper, N.T. Mathew, A. Rapoport, S.B. Phillips, and J.E. Bernstein Intranasal civamide for the treatment of episodic cluster headaches Arch Neurol 59 2002 990 994
40. T. Sasamura, M. Sasaki, C. Tohda, and Y. Kuraishi Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus Neuroreport 9 1998 2045 2048
41. T. Shimizu, H. Toriumi, H. Sato, M. Shibata, E. Nagata, K. Gotoh, and N. Suzuki Distribution and origin of TRPV1 receptor-containing nerve fibers in the dura mater of rat Brain Res 1173 2007 84 91
42. F. Sicuteri, B.M. Fusco, S. Marabini, V. Campagnolo, C.A. Maggi, P. Geppetti, and M. Fanciullacci Beneficial effect of capsaicin application to the nasal mucosa in cluster headache Clin J Pain 5 1989 49 53
43. K. Starowicz, L. Cristino, and V. Di Marzo TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications Curr Pharm Des 14 2008 42 54
44. O. Summ, P.R. Holland, S. Akerman, and P.J. Goadsby TRPV1 receptor blockade is ineffective in different in vivo models of migraine Cephalalgia 31 2011 172 180
45. A. Szallasi, D.N. Cortright, C.A. Blum, and S.R. Eid The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept Nat Rev Drug Discov 6 2007 357 372
46. A. Szallasi, and V. Di Marzo New perspectives on enigmatic vanilloid receptors Trends Neurosci 23 2000 491 497
47. M. Tominaga, M.J. Caterina, A.B. Malmberg, T.A. Rosen, H. Gilbert, K. Skinner, B.E. Raumann, A.I. Basbaum, and D. Julius The cloned capsaicin receptor integrates multiple pain-producing stimuli Neuron 21 1998 531 543
48. D. Ursu, K. Knopp, R.E. Beattie, B. Liu, and E. Sher Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity Eur J Pharmacol 641 2010 114 122
49. I. Vilagi, N. Klapka, and H.J. Luhmann Optical recording of spreading depression in rat neocortical slices Brain Res 898 2001 288 296
50. J. Vriens, G. Appendino, and B. Nilius Pharmacology of vanilloid transient receptor potential cation channels Mol Pharmacol 75 2009 1262 1279